Evidence map›Paper›PMID 38327871›Full record

ArticleNAR genomics and bioinformatics2024

Performing highly parallelized and reproducible GWAS analysis on biobank-scale data.

Sebastian Schönherr, Johanna F Schachtl-Riess, Silvia Di Maio, Michele Filosi, Marvin Mark, Claudia Lamina, Christian Fuchsberger, Florian Kronenberg, Lukas Forer

Abstract read
In one paragraph

Article in NAR genomics and bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sebastian SchönherrInstitute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria. Institutional Address: Schoepfstrasse 41, A-6020 Innsbruck, Austria.
Johanna F Schachtl-RiessInstitute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria. Institutional Address: Schoepfstrasse 41, A-6020 Innsbruck, Austria.
Silvia Di MaioInstitute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria. Institutional Address: Schoepfstrasse 41, A-6020 Innsbruck, Austria.
Michele FilosiInstitute for Biomedicine, Eurac Research, Affiliated Institute of the University of Lübeck, Bolzano, Italy. Institutional Address: Via Alessandro Volta, 21, 39100 Bolzano BZ, Italy.
Marvin MarkInstitute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria. Institutional Address: Schoepfstrasse 41, A-6020 Innsbruck, Austria.
Claudia LaminaInstitute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria. Institutional Address: Schoepfstrasse 41, A-6020 Innsbruck, Austria.ORCID https://orcid.org/0000-0002-5398-5806
Christian FuchsbergerInstitute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria. Institutional Address: Schoepfstrasse 41, A-6020 Innsbruck, Austria.
Florian KronenbergInstitute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria. Institutional Address: Schoepfstrasse 41, A-6020 Innsbruck, Austria.ORCID https://orcid.org/0000-0003-2229-1120
Lukas ForerInstitute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria. Institutional Address: Schoepfstrasse 41, A-6020 Innsbruck, Austria.ORCID https://orcid.org/0000-0003-2139-7329

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genome-wide association studies (GWAS) are transforming genetic research and enable the detection of novel genotype-phenotype relationships. In the last two decades, over 60 000 genetic associations across thousands of traits have been discovered using a GWAS approach. Due to increasing sample sizes, researchers are increasingly faced with computational challenges. A reproducible, modular and extensible pipeline with a focus on parallelization is essential to simplify data analysis and to allow researchers to devote their time to other essential tasks. Here we present nf-gwas, a Nextflow pipeline to run biobank-scale GWAS analysis. The pipeline automatically performs numerous pre- and post-processing steps, integrates regression modeling from the REGENIE package and supports single-variant, gene-based and interaction testing. It includes an extensive reporting functionality that allows to inspect thousands of phenotypes and navigate interactive Manhattan plots directly in the web browser. The pipeline is tested using the unit-style testing framework nf-test, a crucial requirement in clinical and pharmaceutical settings. Furthermore, we validated the pipeline against published GWAS datasets and benchmarked the pipeline on high-performance computing and cloud infrastructures to provide cost estimations to end users. nf-gwas is a highly parallelized, scalable and well-tested Nextflow pipeline to perform GWAS analysis in a reproducible manner.

Identifiers

PMID38327871
PMCPMC10849172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.